The TheraMod rehabilitation device portfolio includes RxDecom®, Spinercise®, and FD-3000™ across spinal decompression, movement rehabilitation, and flexion-distraction equipment categories.
This page focuses specifically on TheraMod’s rehabilitation devices, their equipment categories, intended rehabilitation environments, distributor relevance, manufacturing pathway, and investor review potential.
Unlike the homepage, this page is centered on the company’s current rehabilitation equipment portfolio rather than the broader company overview.
TheraMod states that it is registered with Malaysia’s Medical Device Authority, holds a Malaysian medical device manufacturing licence, and operates under an ISO 13485-certified quality management system certified by TÜV. Licence numbers, registration details, and certificate references should be displayed or linked where available.
Area | Summary |
Portfolio | RxDecom®, Spinercise®, FD-3000™ |
Equipment categories | Spinal decompression, movement rehabilitation, flexion-distraction |
Intended environments | Trained rehabilitation and clinical settings |
Buyer relevance | Clinics, distributors, investors |
Manufacturing direction | Malaysia-based rehabilitation equipment pathway |
Growth focus | Manufacturing, distributors, service systems, Asia expansion |
RxDecom® is TheraMod’s spinal decompression machine developed for rehabilitation environments where guided workflow, positioning, load measurement, touchscreen control, and table access are important.
The device includes:
RxDecom® supports TheraMod’s spinal decompression equipment category within the wider rehabilitation device portfolio.
Spinercise® is TheraMod’s movement rehabilitation device developed for guided rehabilitation movement and structured musculoskeletal rehabilitation workflows.
The device adds a movement-focused rehabilitation category to the portfolio and expands the company beyond decompression and table-assisted equipment.
Spinercise® is relevant to clinics, rehabilitation groups, distributors, and investors reviewing rehabilitation equipment categories.
FD-3000™ is TheraMod’s flexion-distraction rehabilitation device developed for table-assisted rehabilitation environments.
The device includes:
FD-3000™ supports the company’s flexion-distraction rehabilitation equipment category within the broader device portfolio.
The portfolio structure matters because each device supports a different rehabilitation equipment category.
Together, RxDecom®, Spinercise®, and FD-3000™ support:
For investors and distributors, the portfolio demonstrates broader rehabilitation equipment positioning rather than dependence on a single product category.
Device | Category | Main Equipment Focus |
RxDecom® | Spinal decompression machine | Guided positioning, load measurement, touchscreen workflow |
Spinercise® | Movement rehabilitation device | Guided movement and rehabilitation workflow |
FD-3000™ | Flexion-distraction rehabilitation device | Table-assisted positioning and rehabilitation setup |
The rehabilitation device portfolio supports TheraMod’s wider manufacturing and market-development direction.
The next stage includes:
Investors may review the portfolio through manufacturing pathway, equipment categories, distributor readiness, and long-term commercial structure.
Distributors may review the portfolio through service needs, training requirements, documentation systems, and local market fit.
This TheraMod Rehabilitation Device Portfolio page was authored by Theramod’s founder Yama Zafer, D.C; read his bio here. It was last updated on May 20, 2026 to reflect TheraMod’s rehabilitation equipment categories, current device portfolio, distributor pathway, investor information, and Malaysia-based manufacturing direction.
The TheraMod rehabilitation device portfolio includes RxDecom®, Spinercise®, and FD-3000™ across spinal decompression, movement rehabilitation, and flexion-distraction equipment categories.
The portfolio supports TheraMod’s wider rehabilitation equipment direction through manufacturing growth, service systems, distributor onboarding, training pathways, and selected Asia market development.
Together, the devices create a stronger commercial structure for clinics, rehabilitation groups, distributors, investors, and the long-term growth of the TheraMod rehabilitation device portfolio.